Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Q & As for Changes to OHIP+ You may be interested in Opioids October 28, 2020 Post category: Professional Resources Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Professional Resources Opioid Agonist Therapy November 1, 2021 Post category: Professional Resources Therapeutic Options—Focus on Acute Myocardial Infarction November 24, 2021 Post category: Professional Resources
Letter to the Assistant Deputy Minister and Executive Officer Drugs and Devices Division Re: COVID-19 Vaccine Fee Increase May 9, 2022 Post category: Professional Resources
Therapeutic Options—Focus on Acute Myocardial Infarction November 24, 2021 Post category: Professional Resources
